ArticleAdvances in therapy2017

Erratum to: Evaluation of the Efficacy of Sorafenib on Overall Survival in Patients with Hepatocellular Carcinoma using FT Rate: A Devised Index.

Takamasa Ohki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.